Effect of dietary fat on intestinal inflammatory diseases

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue S4, 2013, Pages 33-36

  Hokari, Ryota ^a   Matsunaga, Hisayuki ^a   Miura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Crohn's disease; Immunonutrition; Lymphocyte trafficking; Omega 3 polyunsaturated fatty acid; Small intestine.

Indexed keywords

ADIPONECTIN; DEXTRAN SULFATE; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; COLITIS; CROHN DISEASE; DIETARY INTAKE; DISEASE ACTIVITY; DISEASE EXACERBATION; ENTERITIS; FAT INTAKE; MOUSE; NONHUMAN; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CROHN'S DISEASE; IMMUNONUTRITION; LYMPHOCYTE TRAFFICKING; OMEGA-3 POLYUNSATURATED FATTY ACID; SMALL INTESTINE.;

ADIPONECTIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL ADHESION MOLECULES; CHRONIC DISEASE; COLITIS; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; ILEUM; IMMUNOGLOBULINS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LEUKOCYTES; MICE; MICE, INBRED C57BL; MYOCARDIAL ISCHEMIA; RHEUMATIC FEVER;

EID: 84897609850     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12252     Document Type: Article

References (42)

1. Podolsky DK. Inflammatory bowel disease (1). N. Engl. J. Med. 1991; 325: 928-937.
2. Podolsky DK. Inflammatory bowel disease. N. Engl. J. Med. 2002; 347: 417-429.
3. Satsangi J, Welsh KI, Bunce M etal. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996; 347: 1212-1217.
4. Ogura Y, Bonen DK, Inohara N etal. A frameshift mutation in NOD2 associated with susceptibility to Crohn disease. Nature 2001; 411: 603-606.
5. Hugot JP, Chamaillard M, Zouali H etal. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn disease. Nature 2001; 411: 599-603.
6. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 poly- unsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am. J. Clin. Nutr. 1996; 63: 741-745.
7. Lorenz-Meyer H, Bauer P, Nicolay C etal. Omega 3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn disease. A randomized controlled multicenter trial. Study Group Members (German Crohn Disease Study Group). Scand. J. Gastroenterol. 1996; 31: 778-785.
8. MacLean CH, Mojica WA, Newberry SJ etal. Systematic review of the effects of omega 3 fatty acids in inflammatory bowel disease. Am. J. Clin. Nutr. 2005; 82: 611-619.
9. Bamba T, Shimoyama T, Sasaki M etal. Dietary fat attenuates the benefits of an elemental diet in active Crohn disease: a randomized, controlled trial. Eur. J. Gastroenterol. Hepatol. 2003; 15: 151-157.
10. Miura S, Tsuzuki Y, Hokari R, Ishii H. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn disease. J. Gastroenterol. Hepatol. 1998; 13: 1183-1190.
11. French MA, Parrott AM, Kielo ES etal. Polyunsaturated fat in the diet may improve intestinal function in patients with Crohn disease. Biochim. Biophys. Acta 1997; 1360: 262-270.
12. Alzoghaibi MA, Walsh SW, Willey A, Yager DR, Fowler AA III, Graham MF. Linoleic acid induces interleukin-8 production by Crohn human intestinal smooth muscle cells via arachidonic acid metabolites. Am. J. Physiol. 2004; 286: G528-537.
13. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 2000; 71: 343S-348.
14. Ferna'ndez-Banares F, Cabré E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn disease? A meta-analysis of the randomized clinical trials. JPEN J. Parenter. Enteral Nutr. 1995; 19: 356-364.
15. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn disease. Gastroenterology 1995; 108: 1056-1067.
16. Messori A, Trallori G, D'Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn disease: a meta-analysis. Scand. J. Gastroenterol. 1996; 31: 267-272.
17. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn disease. Cochrane Database Syst. Rev. 2007; 24 (1): CD000542.
18. Palmblad J, Gyllenhammar H. Effect of dietary lipids on immunity and inflammation. APMIS 1988; 96: 571-583.
19. Belluzzi A, Boschi S, Brignola C, Munarini A, Cariani G, Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am. J. Clin. Nutr. 2000; 71: 339S-342.
20. Siguel EN, Lerman RH. Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 1996; 45: 12-23.
21. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohndisease. N. Engl. J. Med. 1996; 334: 1557-1560.
22. Feagan BG, Sandborn WJ, Mittmann U etal. Omega 3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. JAMA 2008; 299: 1690-1697.
23. Cabré E, Mañosa M, Gassull MA. Omega 3 fatty acids and inflammatory bowel diseases-a systematic review. Br. J. Nutr. 2012; 107 (Suppl. 2): S240-252.
24. Shoda R, Matsueda K, Yamato S, Umeda N. Therapeutic efficacyof OMEGA 3 polyunsaturated fatty acid in experimental Crohn disease. J. Gastroenterol. 1995; 30 (Suppl. 8): 98-101.
25. Whiting CV, Bland PW, Tarlton JF. Dietary omega 3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis. Inflamm. Bowel Dis. 2005; 11: 340-349.
26. Campos FG, Waitzberg DL, Habr-Gama A etal. Impact of parenteral omega 3 fatty acids on experimental acute colitis. Br. J. Nutr. 2002; 87 (Suppl. 1): S83-88.
27. Hokari R, Kato S, Matsuzaki K etal. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic. Biol. Med. 2001; 31: 153-163.
28. Pizarro TT, Arseneau KO, Cominelli F. Lessons from genetically engineered animal models XI. Novel mouse models to study pathogenic mechanisms of Crohn disease. Am. J. Physiol. 2000; 278: G665-669.
29. Miura S, Imaeda H, Shiozaki H etal. Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid. Am. J. Physiol. 1993; 264 (5 Pt 1): G828-834.
30. Takeda T, Hosokawa M, Takeshita S etal. A new murine model of accelerated senescence. Mech. Ageing Dev. 1981; 17: 183-194.
31. Matsumoto S, Okabe Y, Setoyama H etal. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 1998; 43: 71-78.
32. Strober W, Nakamura K, Kitani A. The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease. J. Clin. Invest. 2001; 107: 667-670.
33. Inoue T, Tsuzuki Y, Matsuzaki K etal. Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice. J. Leukoc. Biol. 2005; 77: 287-295.
34. Matsuzaki K, Tsuzuki Y, Matsunaga H etal. In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Clin. Exp. Immunol. 2005; 140: 22-31.
35. Matsunaga H, Hokari R, Kurihara C etal. Omega 3 fatty acids exacerbate DSS-induced colitis through decreased adiponectin in colonic subepithelial myofibroblasts. Inflamm. Bowel Dis. 2008; 14: 1348-1357.
36. Matsunaga H, Hokari R, Kurihara C etal. Omega 3 polyunsaturated fatty acids ameliorate the severity of ileitis in the senescence accelerated mice (SAM)P1/Yit mice model. Clin. Exp. Immunol. 2009; 158: 325-333.
37. Greenbloom SL, Steinhart AH, Greenberg GR. Combination ciprofloxacin and metronidazole for active Crohn's disease. Can. J. Gastroenterol. 1998; 12: 53-56.
38. Lal S, Steinhart AH. Antibiotic therapy for Crohn's disease: a review. Can. J. Gastroenterol. 2006; 20: 651-655.
39. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241.
40. Andoh A, Sakata S, Koizumi Y, Mitsuyama K, Fujiyama Y, Benno Y. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm. Bowel Dis. 2007; 13: 955-962.
41. Zhang C, Zhang M, Wang S etal. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 2010; 4: 232-241.
42. Li Q, Zhang Q, Wang C etal. Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant. PLoS ONE 2011; 6: e20460.